Leading Medical Manufacturers Pursue Collaboration with LuminusMicro and Propel Orthopedic Innovations

Q4 2021

Over the past few years, we’ve continued to receive resounding confirmation from leading medical manufacturers and device companies: they simply lack the expertise to replicate or produce LuminusMicro devices.

This validation of our patented designs has translated into tangible commitments and bids from top North American manufacturers. They’re eager to scale up US manufacturing, navigate regulatory compliance, and drive disruptive sales in the market.

During the rigorous engineering and testing phase, we achieved significant breakthroughs in design, leading to the creation of two new families of patent applications filed globally in January of this year. These assets are game-changers because:

• They drastically simplify manufacturing processes, reducing complexity and costs.
• They enhance the durability of our near-microscopic internal components.
• They pave the way for future generations of devices to be even smaller in diameter.

In addition, recent meetings with emerging therapeutic companies in the orthopedic sector have uncovered exciting collaborative opportunities. We’ve identified high-impact avenues that significantly enhance the future launch for our subsidiary, LuminusOrtho.

LuminusMicro devices, with their unique navigation and targeting capabilities at the “micro” scale, serve as the ideal delivery vehicles for various regenerative agents, new therapeutic lasers, micro-surgical probes, and other precise tools. Each of these modalities not only presents new revenue streams for surgeons but also acts as a major catalyst in reducing or even eliminating pain and surgical trauma.